Council of Scientific and Industrial Research - Central Electrochemical Research Institute (CSIR-CECRI), Karaikudi has transferred its recently developed technology on “Electrochemical synthesis of DL-Homocysteine” to Hyderabad based M/s Aurore Life Science Pvt. Ltd. for a sum of ₹24 lakh.
CECRI, which had developed the technology in association with the private pharmaceutical company, transferred the technology at the industrial meet held at CSIR Madras Complex at Taramani on Wednesday, a release from CECRI here, said. The private company had sponsored the research and development project by paying an advance of ₹11.8 lakh, it said.
M. Anbu Kulandainathan, Senior Principal Scientist, CSIR-CECRI, the inventor of the technology, said Citiolone, a derivative of cysteine (an amino acid) was being used to treat severe cold and liver complaints and the new technology was an alternative to it.
“The alternative electrochemical method would synthesis the citiolone by di-sulfide cleavage with electrons as reduction source,” he said.
CECRI also singed a Memorandum of Agreement (MOA) on ‘Development of reusable electrochemical sensor platform for sensing couple of biomarkers for diagnosing chronic kidney diseases and diabetes’ with M/s Uranalytics Healthcare Pvt. Ltd. Bhagalpur, Bihar.
J. Mathiyarasu, Senior Principal Scientist, CSIR-CECRI, and investigator of the project, said the cost effective device would help to diagnose the chronic kidney disease (CKD), kidney stones and diabetes at the early stage. The MOA was signed in the presence of Shekhar C. Mande, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General, CSIR, R. P. Singh, Chief Scientist & In-Charge Mission Directorate, CSIR, New Delhi and N. Kalaiselvi, Director, CSIR-CECRI.
